Inflammatory Disease
Inflammatory Disease - most related articles:
-
Anti inflammatory drugs reduce effectiveness of SSRI antidepressants - 3.2
-
Curcumin in turmeric may delay liver damage, cirrhosis - 3.1
-
TNF blockers will have boxed warning cancer risk - 2.9
-
First stress and then inflammation is the culprit - 2.8
-
Soluble fiber boosts immune system and immunity - 2.7
-
Psoriasis linked to increased heart disease risk - 2.6
-
Anti inflammatory drugs linked with reduced breast cancer risk - 2.5
-
Nigella sativa herbal extract may cure pancreatic cancer - 2.4
-
Allergy drug may reduce obesity and diabetes - 2.3
-
Stress may make you itch more - 2.3
Inflammatory Disease articles
Controlling inflammation in macular degeneration prevents progress of AMDScientists at Trinity College Dublin have discovered that a part of the immune system called the inflammasome is involved in regulating the development of one of the most common forms of blindness, called Age-Related Macular Degeneration (AMD).
Remicade infliximab approved to treat ulcerative colitis in childrenThe U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.
New rheumatoid arthritis criteria aim to recognise RA earlyNew criteria for rheumatoid arthritis (RA), published in the Annals of Rheumatic Diseases, could prevent thousands of people from developing disabling late stage disease, by redefining how RA should be classified.
Two new genes identified causing ankylosing spondylitisWork done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease.
Actemra, tocilizumab approved for Rheumatoid ArthritisGenentech, Inc. , a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRAŽ (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.
Chronic asthma study has potential for new asthma treatmentUK researchers have discovered a key element in the development of chronic asthma explaining why the structure and function of asthmatic airways are changed or ''remodelled'' and how this contributes to chronic asthma.
Teachers' ignorance is putting children with asthma at riskA disturbing three quarters of teachers are not completely confident about what to do if a child in their class has a potentially life-threatening asthma attack, yet asthma is the most common long-term condition affecting children in the UK and on average there are two children with asthma in every classroom.
Vitamin B1 may treat uveitis, a cause of blindnessUniversity of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
Pain relievers seem not to prevent Alzheimer's diseaseA new study shows that nonsteroidal anti-inflammatory drugs (NSAIDs) such as the pain relievers ibuprofen and naproxen do not prevent Alzheimer's disease, but they may instead delay its onset.
Stress may make you itch moreCurrent research suggests that stress may activate immune cells in your skin, resulting in inflammatory skin disease. The related report by Joachim et al., "Stress-induced Neurogenic Inflammation in Murine Skin Skews Dendritic Cells towards Maturation and Migration: Key role of ICAM-1/LFA-1 interactions," appears in the November issue of The American Journal of Pathology.
Colonoscopy associated with reduced colorectal cancer incidencePatients who undergo a complete negative colonoscopy have a reduced incidence of colorectal cancer, confirms a study published in Clinical Gastroenterology and Hepatology.
Aspirin may reduce breast cancer by 20%Anti-inflammatory drugs like aspirin may reduce breast cancer by up to 20 per cent, according to an extensive review carried out by experts at London's Guy's Hospital and published in the March issue of IJCP, the International Journal of Clinical Practice.
Compstatin - new drug for vision loss, macular degenerationUniversity of Florida UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. In a first-of-its-kind safety research study, University of Florida researchers have injected an anti-inflammatory compound into the eye of a person with a sight-robbing disease.
Asacol found effective in ulcerative colitis, proctitisData from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an effective and well-tolerated treatment for patients with all extents of ulcerative colitis (UC), including isolated proctitis.
14 Inflammatory Disease articles listed above.